Scientists have developed a new and improved chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma, a type of blood cancer. 1 This new therapy uses a third-generation CAR...
Scientists Develop More Powerful Cancer-Fighting CellsScientists have created a new type of immune cell, called a CAR-T cell, that’s even better at fighting multiple myeloma, a type of blood...
Scientists Develop More Powerful Cancer-Fighting CellsScientists have created a new type of immune cell, called a CAR-T cell, that’s even better at fighting multiple myeloma, a type of blood...
Scientists are developing a new type of immunotherapy for cancer treatment called Tri-specific killer engagers (TriKEs). TriKEs are designed to activate natural killer (NK) cells, which are a type...
A new study has shown promising results for the use of fourth-generation CAR-T cell therapy in the treatment of breast cancer. CAR-T cell therapy involves genetically modifying a patient’s...
Unlock the Potential of Advanced Therapies: Join Our Crash Course! Are you ready to dive into the world of Advanced Therapeutic Medicinal Products (ATMPs)? Our two-day *Crash Course for...
Researchers have developed a new approach to stimulate T cell responses against breast cancer cells. The researchers identified neoantigens, which are unique markers found on cancer cells, from patient-derived...
Scientists have developed a new type of CAR T cell therapy that could be more effective in treating multiple myeloma, a type of blood cancer. This new therapy uses...
Scientists have developed a new immunotherapy approach for cholangiocarcinoma (CCA), a type of cancer that originates in the bile ducts. The researchers identified neoantigens, which are unique markers found...
2023 Frontiers in Basic Immunology The Center for Cancer Research at the National Cancer Institute is hosting a two-day international symposium on September 27-28, 2023 entitled 2023 Frontiers in...